Search
                    Oregon Paid Clinical Trials
A listing of 1212  clinical trials  in Oregon  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            661 - 672 of 1212
        
                Oregon is currently home to 1212 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Portland, Eugene, Medford and Clackamas. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
                                
            
            
        Recruiting
                            
            
                This open label ascending dose study is designed to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of AV-380 in cancer patients with Cachexia. AV-380 is an immunoglobulin (Ig) G1 monoclonal antibody (mAb) intended to bind circulating human growth differentiation factor 15 (GDF-15), a cytokine involved in cancer-induced cachexia.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/13/2025
            
            Locations: Oregon Health and Science University, Portland, Oregon         
        
        
            Conditions: Cachexia
        
            
        
    
                
                                    Clarifying the Optimal Application of SLT Therapy Trial
                                
            
            
        Recruiting
                            
            
                The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeating it.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/13/2025
            
            Locations: Devers Eye Institute, Portland, Oregon         
        
        
            Conditions: Glaucoma and Ocular Hypertension
        
            
        
    
                
                                    G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
                                
            
            
        Recruiting
                            
            
                The main objectives of this study are to confirm the long-term safety, performance, and clinical benefits of the G7 Acetabular Shells when used with the Vivacit-E and Longevity HXLPE liners and instrumentation in primary and revision total hip arthroplasty.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/13/2025
            
            Locations: Slocum Center for Orthopedics & Sports Medicine, Eugene, Oregon         
        
        
            Conditions: Total Hip Arthroplasty, Degenerative Joint Disease of Hip, Avascular Necrosis of Hip, Rheumatoid Arthritis of Hip, Osteoarthritis, Hip, Osteoarthritis of Hip, Fractures, Hip, Fracture of Hip
        
            
        
    
                
                                    Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
                                
            
            
        Recruiting
                            
            
                The Family Caregiver Survey is a one-time, 30-minute, online survey for people living with and caring for a family member with dementia. The goal of this research is to explore the needs of family caregivers, specifically when it comes to managing swallowing difficulties (dysphagia).             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/12/2025
            
            Locations: Remote study offered by the University of Oregon, Eugene, Oregon         
        
        
            Conditions: Dementia, Dysphagia, Dementia Alzheimers, Dementia, Vascular, Dementia, Mixed, Dementia With Lewy Bodies, Dementia Frontal, Dementia, Mild, Dementia Moderate, Dementia Severe, Parkinson Disease Dementia, Dementia Frontotemporal
        
            
        
    
                
                                    A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
                                
            
            
        Recruiting
                            
            
                This is an adaptive Phase 2/3 multicenter, double-blind, placebo-controlled, randomized, parallel, 2 arm study to evaluate the efficacy and safety of DA-1229 compared to placebo in patients with calcific aortic valve disease with mild to moderate aortic stenosis. There are 2 arms in this study to which patients will be randomized in a ratio of 1:1 to receive the DA-1229 or placebo orally once daily for a period of 104 weeks. The 2 arms are: placebo and DA-1229 10 mg Group.
The study will have t...  Read More             
        
        
    Gender:
                ALL
            Ages:
                35 years and above
            Trial Updated:
                06/12/2025
            
            Locations: Oregon Health & Science University, Portland, Oregon         
        
        
            Conditions: Calcific Aortic Valve Disease
        
            
        
    
                
                                    Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks
                                
            
            
        Recruiting
                            
            
                Malnutrition significantly contributes to the disability and mortality associated with Alzheimer's disease and Alzheimer's disease-related dementias. Thus, nutritional status is one important, modifiable clinical factor for maintaining physical and cognitive health among persons with dementia (PWD). This project will pilot an innovative approach to enhancing nutrition through the use of transitional-state snack supplements, or foods that start as one texture and change to another.
Specifically,...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                06/12/2025
            
            Locations: University of Oregon, Eugene, Oregon         
        
        
            Conditions: Dementia, Nutrition Poor
        
            
        
    
                
                                    A Study of Mosliciguat in PH-ILD
                                
            
            
        Recruiting
                            
            
                This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD).             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                06/11/2025
            
            Locations: Summit Health, Bend, Oregon         
        
        
            Conditions: Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases, Vascular Diseases, Cardiovascular Diseases, Fibrosis
        
            
        
    
                
                                    CGM for Management of Type 2 Diabetes in Pregnancy
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn about all risk factors (biologic, personal, social) for maternal and infant complications in type 2 diabetes pregnancies. The main questions it aims to answer are:
1. Does continuous glucose monitoring improve infant outcomes compared to self-monitoring of blood glucose?
2. Does continuous glucose...  Read More             
        
        
    Gender:
                FEMALE
            Ages:
                Between 18 years and 50 years
            Trial Updated:
                06/11/2025
            
            Locations: Oregon Health and Science University, Portland, Oregon         
        
        
            Conditions: Type 2 Diabetes Mellitus (T2DM), Pregnancy
        
            
        
    
                
                                    Using Aspirin to Improve Immunological Features of Ovarian Tumors
                                
            
            
        Recruiting
                            
            
                The purpose of the study is to evaluate the effectiveness of aspirin with neoadjuvant chemotherapy for decreasing markers of immune suppression in the tumor at interval debulking surgery, in women with diagnosed ovarian, fallopian tube, or peritoneal carcinoma             
        
        
    Gender:
                FEMALE
            Ages:
                18 years and above
            Trial Updated:
                06/11/2025
            
            Locations: Oregon Health and Science University, Portland, Oregon         
        
        
            
        
    
                
                                    Comprehensive HHT Outcomes Registry of the United States (CHORUS)
                                
            
            
        Recruiting
                            
            
                The Comprehensive HHT Outcomes Registry of the United States (CHORUS) is an observational registry of patients diagnosed with Hereditary Hemorrhagic Telangiectasia (HHT). The purpose of this study is to better understand HHT, the symptoms and complications it causes, and the impact the disease has on people's lives. The investigators will collect long-term information about the participant, allowing us to understand how the disease changes over time, and what factors can influence those changes....  Read More             
        
        
    Gender:
                ALL
            Ages:
                All
            Trial Updated:
                06/10/2025
            
            Locations: Oregon Health and Science University, Portland, Oregon         
        
        
            Conditions: Hereditary Hemorrhagic Telangiectasia, Arteriovenous Malformations, Telangiectasia, Epistaxis, GastroIntestinal Bleeding, Cerebral Arteriovenous Malformations, Vascular Malformation
        
            
        
    
                
                                    TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to improve upon the TINI study treatment. The study will test the ability of a type of immunotherapy called blinatumomab to clear persistent leukemia. Blinatumomab targets CD19 which is located on the leukemia cells outer membrane.             
        
        
    Gender:
                ALL
            Ages:
                1 year and below
            Trial Updated:
                06/10/2025
            
            Locations: Doernbecher Children's Hospital, Portland, Oregon         
        
        
            Conditions: Lymphoblastic Leukemia
        
            
        
    
                
                                    Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
                                
            
            
        Recruiting
                            
            
                This is a multi-site comparative effectiveness randomized controlled trial (RCT) comparing annual fecal immunochemical testing (FIT) and colonoscopy for post-polypectomy surveillance among adults aged 65-82 with a history of colorectal polyps who are due for surveillance colonoscopy.             
        
        
    Gender:
                ALL
            Ages:
                Between 65 years and 82 years
            Trial Updated:
                06/10/2025
            
            Locations: Kaiser Permanente Northwest, Portand, Oregon         
        
        
            Conditions: Colorectal Polyp, Colorectal Neoplasms, Colorectal Adenoma, Colorectal Cancer, Digestive System Disease
        
            
        
    